In a recent survey, 89% of clinical adjudication users agreed clinical adjudication provides value to clinical trials. Why? Because using unbiased experts to evaluate a drug or device against predetermined criteria helps determine patient safety and clinical efficacy. Join two Bioclinica experts for a discussion of these and other survey results to understand how they could impact your studies.

In the webinar, we will discuss:

• The survey findings on the role of clinical adjudication in clinical trials
• The top three hurdles in using clinical adjudication for clinical trials
• The two most valuable services a clinical adjudication partner can provide
• Several considerations to evaluate when selecting a clinical adjudication partner for your next trial